Susquehanna International Group, LLP Inmune Bio, Inc. Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2025

A detailed history of Susquehanna International Group, LLP transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 40,295 shares of INMB stock, worth $298,585. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,295

Previous 23,495 71.5%

Holding current value

$298,585

Previous $109,000 188.07%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$4.93 - $10.48 $82,824 - $176,064	16,800 Added 71.5%	40,295 $314,000
Q4 2024 Feb 14, 2025	BUY	$4.4 - $6.43 $103,378 - $151,072	23,495 New	23,495 $109,000
Q2 2024 Aug 15, 2024	SELL	$7.15 - $11.84 $801,243 - $1.33 Million	-112,062 Reduced 72.38%	42,772 $377,000
Q1 2024 May 07, 2024	BUY	$10.53 - $14.01 $1.17 Million - $1.56 Million	110,998 Added 253.21%	154,834 $1.82 Million
Q4 2023 Feb 14, 2024	BUY	$6.6 - $11.52 $79,167 - $138,182	11,995 Added 37.67%	43,836 $493,000
Q3 2023 Nov 14, 2023	SELL	$6.61 - $10.9 $60,613 - $99,953	-9,170 Reduced 22.36%	31,841 $215,000
Q2 2023 Aug 11, 2023	SELL	$6.5 - $10.09 $192,569 - $298,926	-29,626 Reduced 41.94%	41,011 $372,000
Q1 2023 May 16, 2023	BUY	$6.01 - $10.18 $338,621 - $573,571	56,343 Added 394.17%	70,637 $456,000
Q4 2022 Feb 14, 2023	SELL	$6.13 - $7.96 $58,106 - $75,452	-9,479 Reduced 39.87%	14,294 $90,000
Q3 2022 Nov 14, 2022	BUY	$6.04 - $10.44 $143,588 - $248,190	23,773 New	23,773 $147,000
Q1 2022 May 16, 2022	SELL	$6.42 - $11.39 $247,401 - $438,925	-38,536 Reduced 42.54%	52,042 $438,000
Q4 2021 Feb 14, 2022	BUY	$9.97 - $20.38 $80,248 - $164,038	8,049 Added 9.75%	90,578 $924,000
Q3 2021 Nov 15, 2021	BUY	$14.13 - $27.85 $96,295 - $189,797	6,815 Added 9.0%	82,529 $1.6 Million
Q2 2021 Aug 11, 2021	BUY	$9.29 - $19.33 $396,144 - $824,269	42,642 Added 128.94%	75,714 $1.33 Million
Q1 2021 May 17, 2021	BUY	$11.61 - $26.85 $383,965 - $887,983	33,072 New	33,072 $393,000
Q2 2020 Aug 14, 2020	SELL	$3.1 - $6.09 $35,473 - $69,687	-11,443 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$2.21 - $6.15 $25,289 - $70,374	11,443 New	11,443 $38,000

Others Institutions Holding INMB

# of Institutions

Shares Held

6.87M

Call Options Held

202K

Put Options Held

104K

View Full List

About Inmune Bio, Inc.

Ticker INMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,946,000
Market Cap $133M
Description
INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...

More about INMB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Inmune Bio, Inc. Transaction History